Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
algorithm
ambient cistern
ambient cistern, effacement
amyloid angiopathy, cerebral
aneurysm
aneurysm, intracranial
aneurysm, intracranial, acute deterioration
aneurysm, intracranial, treatment of
angiography, cerebral
anticoagulant, complications of
anticoagulant, restarting
anticoagulant, reversal of
anticoagulant, treatment
anticonvulsants
asymptomatic
ataxia
basal ganglia, hemorrhage
basal ganglia, infarction
basilar artery
basilar artery occlusion
blood pressure
blood pressure, control
blood pressure, lowering
brainstem, hematoma
brainstem, hemorrhage, primary
brainstem, vascular malformation of
carotid artery disease
carotid artery occlusion, intracranial
CAT scan
CAT scan, abnormal
CAT scan, angiography
CAT scan, mass effect on
CAT scan, stereotactic localization
cerebellar hemorrhage
cerebellar infarction
cerebral embolism, mechanical extraction
cerebral infarction, hemorrhagic
cerebral venous infarction
cerebral venous thrombosis
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, clinical diagnosis
cerebrovascular accident, complications with
cerebrovascular accident, nontreatment of
cerebrovascular accident, prevention of
cerebrovascular accident, prognosis in
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, time of onset
cerebrovascular accident, time to treatment
cerebrovascular accident, volume
cerebrovascular accident, work up for
cerebrovascular disease, surgical treatment of
clot burden
clot length
complications
controversies in neurology
coronary thrombolysis
coumarin
craniectomy, decompressive
craniotomy
critical care unit
disability, neurological
do not resuscitate
door to needle time
drug abuse
dying
efficacy
emergencies, neurologic
emergency room
emergency room, treatment of stroke
endoscopic surgery
endovascular therapy
ENRICH trial
epidemiology of neurology
evidence-based research
fibrinolytic agents
fibrinolytic agents, complications
fibrinolytic therapy, selection criteria
fibrinolytic therapy, timing of administration
gadolinium
gastrointestinal bleeding
Glasgow coma score
head injury
headache
hematoma, intracerebral
hemorrhage, putamenal
hemorrhage, thalamic
hemostatic therapy
heralding manifestation
herniation syndromes, intracranial
hydrocephalus
hydrocephalus, treatment of
hypertension
iatrogenic neurologic disorders
incidence
intracerebral hemorrhage
intracerebral hemorrhage, causes of
intracerebral hemorrhage, clot evacuation
intracerebral hemorrhage, differential diagnosis of
intracerebral hemorrhage, incidence of
intracerebral hemorrhage, lobar
intracerebral hemorrhage, location of
intracerebral hemorrhage, medical management
intracerebral hemorrhage, multiple
intracerebral hemorrhage, pathophysiology
intracerebral hemorrhage, progression of
intracerebral hemorrhage, recurrent
intracerebral hemorrhage, small
intracerebral hemorrhage, treatment of
intracerebral hemorrhage, volume
intracranial hemorrhage
intracranial pressure monitoring
intracranial pressure, increased
intracranial pressure, increased, treatment of
intraventricular hemorrhage
intraventricular hemorrhage, clot evacuation
intraventricular hemorrhage, treatment
intubation
ischemic core
level of consciousness
level of consciousness, decreased
life expectancy
life support, withdrawal of
life support, withholding of
malformation, vascular
malformation, vascular, cerebral
malformation, vascular, cryptic
microsurgery
middle cerebral artery
middle cerebral artery, occlusion of
minimally invasive surgery
mortality
MRI
MRI, abnormal
MRI, ADC maps
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, diffusion weighted
MRI, early changes in CVA
MRI, gradient echo, vessel sign
MRI, susceptibility weighted
MRI, volumetry
myocardial infarction
myocardial infarction, acute
neoplasm, metastatic to CNS
neoplasm, metastatic to CNS, hemorrhagic
neoplasm, metastatic to CNS-hemorrhage into
neoplasm, primary of CNS
neoplasm, primary of CNS-hemorrhage in
neurologic complications of, surgery
neurologic disease, diagnoses of
neurologic examination
neurological intensive care
patient selection
platelet inhibiting drugs
pontine hemorrhage
practice guidelines
prevention of neurologic disorders
prognosis
race
Rankin score
recanalization, arterial
recombinant activated factor VII
reperfusion
Retriever Device
review article
risk factors
safety
seizure
seizure, prevention of
shunt procedure, ventricular
solitaire device
Spot sign
stereotaxic surgery
STITCH II trial
streptokinase
subarachnoid hemorrhage
subdural hematoma
SWIFT PRIME Trials
syncope
thrombectomy
tissue plasminogen activator, intravenous
tranexamic acid
treatment of neurologic disorder
urokinase
ventriculostomy
ventriculostomy, endoscopic
vertigo
workup
Showing articles 550 to 600 of 1391 << Previous Next >>

Endovascular Approaches to Acute Stroke, Part 1: Drugs, Devices, and Data
AJNR 30:649-661, Nogueira,R.G.,et al, 2009

Telemedicine Versus Telephone for Remote Emergency Stroke Consultations: A Critically Appraised Topic
The Neurologist 15:163-166, Capampngan,D.J.,et al, 2009

Brain Lesions Are Most Often Reversible in Acute Thrombotic Thrombocytopenic Purpura
Neurol 73:66-70, Burrus,T.M.,et al, 2009

Intraarterial Thrombolysis Within the First Three Hours After Acute Ischemic Stroke in Selected Patients
Stroke 40:2611-2612,2615, Moonis,M., 2009

Is Intraarterial tPA Within 3 Hours the Treatment of Choice for Selected Stroke Patients? No
Stroke 40:2613-2614,2615, Lindley,R.I., 2009

Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window: Joint Outcome Table Analysis of the ECASS 3 Trial
Stroke 40:2433-2437,2295, Saver,J.L.,et al, 2009

Efficacy and Safety of Tissue Plasminogen Activator 3 to 4.5 Hours After Acute Ischemic Stroke: A Metaanalysis
Stroke 40:2438-2441, Lansberg,M.G.,et al, 2009

Stroke Therapy Academic Industry Roundtable (STAIR) Recommendations for Extended Window Acute Stroke Therapy Trials
Stroke 40:2594-2600, Saver,J.L.,et al, 2009

Smoking Is Associated with Increased Lesion Volumes and Brain Atrophy in Multiple Sclerosis
Neurol 73:504-510, Zivadinov,R.,et al, 2009

Transcranial Ultrasound in Clinical Sonothrombolysis (TUCSON) Trial
Ann Neurol 66:28-38, Molina,C.A.,et al, 2009

Fully-Automated Quantification of Regional Brain Volumes for Improved Detection of Focal Atrophy in Alzheimers Disease
AJNR 30:578-580, Brewer, J.B.,et al, 2009

Stroke Syndrome Secondary to Hypercoagulability of Lung Cancer
Commun Oncol 5:595-596, Lim, B. & Henry, D.H., 2008

Risk Factors of Cerebral Vein and Sinus Thrombosis
Front Neurol Neurosci 23:23-54, de Freitas, G.R. & Bogousslavsky, J., 2008

Treating Patients with Wake-Up Stroke: The Experience of the AbESTT-II Trial
Stroke 39:3277-3282, Adams,H.P.,et al, 2008

Managing the Anticoagulated Patient with Atrial Fibrillation at High Risk of Stroke Who Needs Coronary Intervention
BMJ 337:1110-1111, Lip,G.Y.H., 2008

Review of Tissue Plasminogen Activator, Ischemic Stroke, and Potential Legal Issues
Arch Neurol 65:1429-1433, Liang,B.A.,et al, 2008

Picturing Multiple Sclerosis: Conventional and Diffusion Tensor Imaging
Semin Neurol 28:453-466, Fox,R.J., 2008

A Case of Cocaine-Induced Basilar Artery Thrombosis
Nat Clin Pract Neurol 4:622-626, MacEwen,C., et al, 2008

Ischemic Stroke and ICU Care
Semin Neurol 28:645-656, Llinas, R, 2008

Rapid Assessment of Perfusion-Diffusion Mismatch
Stroke 39:75-81, Butcher,K.,et al, 2008

Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stoke: Results of an International Phase III Trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)
Stroke 39:89-99, Adams,H.P.,Jr.,et al, 2008

Influence of the Stroke Code Activation Source on the Outcome of Acute Ischemic Stroke Patients
Neurol 70:1238-1243,1232, P�rez de la Ossa,N.,et al, 2008

Is it Time for Neurohospitalists?
Neurol 70:1282-1288, Freeman,W.D.,et al, 2008

Mechanical Thrombectomy for Acute Ischemic Stroke: Final Results of the Multi MERCI Trial
Stroke 39:1205-1212, Smith,W.S.,et al, 2008

Solid Cerebral Microemboli and Cerebrovascular Symptoms in Patients With Prosthetic Heart Valves
Stroke 39:1159-1164, Skjelland,M.,et al, 2008

Intraventricular Hemorrhage: Anatomic Relationships and Clinical Implications
Neurol 70:848-852, Hallevi,H.,et al, 2008

Endovascular Thrombectomy and Thrombolysis for Severe Cerebral Sinus Thrombosis: A Prospective Study
Stroke 39:1487-1490, Stam,J.,et al, 2008

Sonothrombolysis With Transcranial Color-Coded Sonography and Recombinant Tissue-Type Plasminogen Activator in Acute Middle Cerebral Artery Main Stem Occlusion: Results From a Randomized Study
Stroke 39:1470-1475,1404, Eggers,J.,et al, 2008

Intra-Arterial Thrombolysis of Acute Iatrogenic Intracranial Arterial Occlusion Attributable to Neuroendovascular Procedures or Coronary Angiography
Stroke 39:1491-1495, Arnold,M.,et al, 2008

Local Intraarterial Fibrinolysis Administered in Aliquots for the Treatment of Central Retinal Artery Occlusion: The Johns Hopkins Hospital Experience
Stroke 39:1746-1750, Aldrich,E.M.,et al, 2008

Neuroimaging in Acute Posterior Cerebral Artery Infarction
The Neurologist 14:170-180, Finelli,P.F., 2008

Stroke
Lancet 371:1612-1623, Donnan,G.A.,et al, 2008

Safety of Antiplatelet Therapy Prior to Intravenous Thrombolysis in Acute Ischemic Stroke
Arch Neurol 65:607-611,575, Uyttenboogaart,M.,et al, 2008

Ischemic Stroke in Patients With Primary Brain Tumor
Neurol 70:2314-2320, Kreisl,T.N.,et al, 2008

Treatment of Childhood Arterial Ischemic Stroke
Ann Neurol 63:679-696, Bernard,T.J.,et al, 2008

Iatrogenic Arterial Perforation During Acute Stroke Interventions
AJNR 29:974-975, Nguyen,T.N.,et al, 2008

Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
NEJM 358:2127-2137,2174, Mayer,S.A.,et al, 2008

Thrombolysis in Patients With Marked Clinical Fluctuations in Neurologic Status Due to Cerebral Ischemia
Arch Neurol 65:1041-1043,1017, Ozdemir,O.,et al., 2008

Percutaneous Clot Removal Devices in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
Arch Neurol 65:1024-1030, Stead,L.G.,et al., 2008

MR Imaging-Based Decision in Thrombolytic Therapy for Stroke on Awakening: Report of 2 Cases
AJRN 29:1314-1316, Iosif,C.,et al., 2008

Denture Cream: An Unusual Source of Excess Zinc, Leading to Hypocupremia and Neurologic Disease
Neurol 71:639-643, Nations,S.P.,et al., 2008

Prognostic Significance of Blood Pressure Variability After Thrombolysis in Acute Stroke
Neurol 71:552-558, Delgado-Mederos,R.,et al., 2008

Anticoagulation After Cardioembolic Stroke: To Bridge or Not to Bridge
Arch Neurol 65:1169-1173,1157, Hallevi,H.,et al., 2008

Treatment of Cervical Artery Dissection: A Systematic Review and Meta-Analysis
JNNP 79:11222-1127, Menon,R.,et al, 2008

Thrombolysis with Alteplase 3-4.5 h After Ischaemic Stroke (SITS-ISTR): An Observational Study
Lancet 372:1303-1309, Wahlgren,N.,et al, 2008

Thrombolysis with Alteplase 3 to 4.5 Hours After Acute Ischemic Stroke
NEJM 359:1317-1329,1393, Hacke,W.,et al, 2008

Symptomatic Intracerebral Hemorrhage and Recanalization After IV rt-PA: A Multicenter Study
Neurol 71:1304-1312, Saqqur,M.,et al, 2008

Thrombolysis for Ischemic Stroke in Children. Data From the Natioinwide Inpatient Sample
Stroke 38:1850-1854,1722, Janjua,N.,et al, 2007

Evaluation of the Clinical-Diffusion and Perfusion-Diffusion Mismatch Models in DEFUSE
Stroke 38:1826-1830,1718, Lansberg,M.G.,et al, 2007

Estimated Cost Savings of Increased Use of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Canada
Storke 38:1952-1955,1732, Yip,T.R. &Demaerschalk,B.M., 2007



Showing articles 550 to 600 of 1391 << Previous Next >>